Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IRS pushes April 15 tax deadline to May 15
IRS pushes April 15 tax deadline to May 15
Funges taking flight again
NFT's all exploding. Big boards on down to OTC
TKAT meowwww
NFT cheapies
UAMM
SMKG
CORG
IMTL
Yes sir. Better find them cheap NFT plays. Bitcoin 2.0 this summer imo
Better find them cheap NFT plays.. Bitcoin 2.0 this summer imo
TKAT.. NFT play, holy mover
TKAT.. NFT play holy mover
TKAT NFT play exploding
Non current... Stop sign OTC markets. Why they let this slip back after attorney letter in June?
Yeah, not even a website yet. Still the stone/ jewelery website on OTC markets
Big drop
SMK* came out with NFT news a couple days ago
Fomo pop
Oil in the ground, is not money in the bank.
No filings?
Why didn't they release the newsi the 8-k. Smh
GWHP~ Rocket with 20m float
Current Report Filing (8-k)
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2021
GLOBAL WHOLEHEALTH PARTNERS CORPORATION
(Exact name of registrant as specified in its charter)
Nevada000-5603546-2316220(State or other jurisdiction
of incorporation)(Commission File Number)(IRS Employer
Identification No.)
1402 El Camino Real
San Clemente, CA
92672(Address of Principal Executive Offices)(Zip Code)
Registrant's telephone number, including area code (714) 392-9752
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.?
Section 8 - Other Events
Item 8.01 Other Events.
On February 27, 2021, Global WholeHealth Partners Corp (the “Company”) received from Nunzia Pharmaceutical (“Nunvia) the full right as a distributor of Nunzia to sell the ADZ 1222 Covid 19 Vaccine (“Astra-Zeneca vaccine”) by Thameen Healthcare Trading LLC (“Thameen”). The Company will sell and distribute the Astra-Zeneca vaccine in accordance with the guidelines that were given to Nunzia by Thameen who are working with world bodies like the WHO and other Statutory Bodies established for the supply of vaccines, across the world to help in faster inoculation across the world.
A copy of the letter to sell from Nunzia to the Company and letter to sell from Thameen to Nunzia is furnished as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.
Section 9 – Financial Statement and Exhibits
Item 9.01 Financial Statements and Exhibits.
Exhibit No.DocumentLocation99.1Letter to sell vaccines from Nunzia Pharmaceutical to Global WholeHealth Partners, Corp., dated February 27, 2021Filed Herewith99.2Letter to sell from Thameen Healthcare Trading LLC to Nunzia Pharmaceutical, dated February 26, 2021 Filed Herewith
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GLOBAL WHOLEHEALTH PARTNERS CORPORATION
(Registrant)
Date: March 2, 2021
By: /s/ Charles Strongo
Charles Strongo
Chief Executive Officer
3
GWHP- Rocket with 20m float
GWHP... BIG 8-k just hit
Current Report Filing (8-k)
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2021
GLOBAL WHOLEHEALTH PARTNERS CORPORATION
(Exact name of registrant as specified in its charter)
Nevada000-5603546-2316220(State or other jurisdiction
of incorporation)(Commission File Number)(IRS Employer
Identification No.)
1402 El Camino Real
San Clemente, CA
92672(Address of Principal Executive Offices)(Zip Code)
Registrant's telephone number, including area code (714) 392-9752
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.?
Section 8 - Other Events
Item 8.01 Other Events.
On February 27, 2021, Global WholeHealth Partners Corp (the “Company”) received from Nunzia Pharmaceutical (“Nunvia) the full right as a distributor of Nunzia to sell the ADZ 1222 Covid 19 Vaccine (“Astra-Zeneca vaccine”) by Thameen Healthcare Trading LLC (“Thameen”). The Company will sell and distribute the Astra-Zeneca vaccine in accordance with the guidelines that were given to Nunzia by Thameen who are working with world bodies like the WHO and other Statutory Bodies established for the supply of vaccines, across the world to help in faster inoculation across the world.
A copy of the letter to sell from Nunzia to the Company and letter to sell from Thameen to Nunzia is furnished as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.
Section 9 – Financial Statement and Exhibits
Item 9.01 Financial Statements and Exhibits.
Exhibit No.DocumentLocation99.1Letter to sell vaccines from Nunzia Pharmaceutical to Global WholeHealth Partners, Corp., dated February 27, 2021Filed Herewith99.2Letter to sell from Thameen Healthcare Trading LLC to Nunzia Pharmaceutical, dated February 26, 2021 Filed Herewith
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GLOBAL WHOLEHEALTH PARTNERS CORPORATION
(Registrant)
Date: March 2, 2021
By: /s/ Charles Strongo
Charles Strongo
Chief Executive Officer
3
GWHP... BIG 8-k just hit
Current Report Filing (8-k)
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 2021
GLOBAL WHOLEHEALTH PARTNERS CORPORATION
(Exact name of registrant as specified in its charter)
Nevada000-5603546-2316220(State or other jurisdiction
of incorporation)(Commission File Number)(IRS Employer
Identification No.)
1402 El Camino Real
San Clemente, CA
92672(Address of Principal Executive Offices)(Zip Code)
Registrant's telephone number, including area code (714) 392-9752
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.?
Section 8 - Other Events
Item 8.01 Other Events.
On February 27, 2021, Global WholeHealth Partners Corp (the “Company”) received from Nunzia Pharmaceutical (“Nunvia) the full right as a distributor of Nunzia to sell the ADZ 1222 Covid 19 Vaccine (“Astra-Zeneca vaccine”) by Thameen Healthcare Trading LLC (“Thameen”). The Company will sell and distribute the Astra-Zeneca vaccine in accordance with the guidelines that were given to Nunzia by Thameen who are working with world bodies like the WHO and other Statutory Bodies established for the supply of vaccines, across the world to help in faster inoculation across the world.
A copy of the letter to sell from Nunzia to the Company and letter to sell from Thameen to Nunzia is furnished as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.
Section 9 – Financial Statement and Exhibits
Item 9.01 Financial Statements and Exhibits.
Exhibit No.DocumentLocation99.1Letter to sell vaccines from Nunzia Pharmaceutical to Global WholeHealth Partners, Corp., dated February 27, 2021Filed Herewith99.2Letter to sell from Thameen Healthcare Trading LLC to Nunzia Pharmaceutical, dated February 26, 2021 Filed Herewith
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GLOBAL WHOLEHEALTH PARTNERS CORPORATION
(Registrant)
Date: March 2, 2021
By: /s/ Charles Strongo
Charles Strongo
Chief Executive Officer
3
Stop sign, no financials in 2 years.
People are staying away from them or should. To many getting suspended
Where are you seeing Carepay " Holdings" ?
Sos shows Carepay Inc
Yes... Name change to Carepay Inc hit sos
ADNY - Name change to Carepay and it's massive.
Carepay made Forbes Top 10 article in Jan, companies to change the world.
Along side of Zoom, Alibaba, PayPal, Blackrock.
https://www.carepay.com/news-article/fortunes-change-the-world-lists-carepay-safaricom-in-top-10
Carepay made Forbes Top 10 article in Jan, companies to change the world.
Along side of Zoom, Alibaba, PayPal, Blackrock.
https://www.carepay.com/news-article/fortunes-change-the-world-lists-carepay-safaricom-in-top-10
TAOP Blockchain boom is here
TAOP Blockchain boom is here
Sec delinquent.... Smh
Bitcoin oh my
Oh boy
Talking about blockchain same day trades :)
Bitcoin stocks with the rug pull. Oh my
Bitcoin stocks with the rug pull... Oh my
No financials filed sense 2015!?
Sounds like blockchain will be used for same day settlement on trades. T-0
Sounds like blockchain will be used for same day settlement on trades. T-0
Alliance Recovery Corp trades under ticker ARVY